Published in Ther Drug Monit on August 01, 2016
An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs R D (2016) 0.75
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia (2008) 2.74
[Epilepsy and religion]. Tidsskr Nor Laegeforen (2011) 2.58
Nonadherence to treatment causing acute hospitalizations in people with epilepsy: an observational, prospective study. Epilepsia (2014) 2.08
Valproate: past, present, and future. CNS Drug Rev (2003) 1.77
LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol (2002) 1.48
Is elevated pre-ictal heart rate associated with secondary generalization in partial epilepsy? Seizure (2010) 1.45
[Changed health requirements regarding driver's licence for people with epilepsy]. Tidsskr Nor Laegeforen (2011) 1.39
[Anticonvulsants and drivers license--new guidelines should be revised]. Tidsskr Nor Laegeforen (2012) 1.38
[The prescription registry and abuse of pregabalin]. Tidsskr Nor Laegeforen (2011) 1.37
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X). Epilepsy Res (2010) 1.35
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res (2012) 1.24
Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res (2006) 1.23
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia (2005) 1.20
Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res (2008) 1.20
The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich repeat proteins. FEBS Lett (2002) 1.06
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res (2004) 1.05
Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia (2005) 1.03
Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr Genet (2003) 1.02
Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia (2007) 0.99
A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav (2005) 0.99
Modifications of antiepileptic drugs for improved tolerability and efficacy. Perspect Medicin Chem (2008) 0.98
Host factors affecting antiepileptic drug delivery-pharmacokinetic variability. Adv Drug Deliv Rev (2011) 0.98
Second-generation antiepileptic drugs and pregnancy: a guide for clinicians. Expert Rev Neurother (2012) 0.97
Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res (2004) 0.96
Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions. Epilepsy Res (2009) 0.95
Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists. Nord J Psychiatry (2006) 0.94
Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol (2010) 0.93
Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res (2008) 0.93
Pharmacological management of epilepsy: recent advances and future prospects. Drugs (2008) 0.91
The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disord (2003) 0.91
Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res (2011) 0.90
A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure (2003) 0.88
Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Ther Drug Monit (2012) 0.87
Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study. Ther Drug Monit (2003) 0.87
Copy number variants in adult patients with Lennox-Gastaut syndrome features. Epilepsy Res (2013) 0.86
Headaches add to the burden of epilepsy. J Headache Pain (2007) 0.81
Clinical use of antiepileptic drugs at a referral centre for epilepsy. Seizure (2007) 0.81
Safety aspects of antiepileptic drugs--focus on pharmacovigilance. Pharmacoepidemiol Drug Saf (2011) 0.81
Is dietary caffeine involved in seizure precipitation? Epilepsy Behav (2013) 0.81
Relating fatty acid composition in human fingertip blood to age, gender, nationality and n-3 supplementation in the Scandinavian population. Int J Food Sci Nutr (2012) 0.81
Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects. Epilepsy Behav (2004) 0.81
An easily performed group education programme for patients with uncontrolled epilepsy--a pilot study. Seizure (2003) 0.80
Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure (2008) 0.79
Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure (2007) 0.79
Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy. Epilepsy Behav (2013) 0.78
Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity. Acta Ophthalmol (2011) 0.78
Long-term stability of GHB in post-mortem samples and samples from living persons, stored at -20°C, using fluoride preservatives. Forensic Sci Int (2012) 0.78
Partial epilepsy with "ecstatic" seizures. Epilepsy Behav (2003) 0.77
Benzoylated uronic acid building blocks and synthesis of N-uronate conjugates of lamotrigine. Molecules (2012) 0.77
SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features. Epilepsy Behav (2009) 0.77
Lamotrigine serum concentrations throughout the menstrual cycle--a study of 2 cases. Clin Neuropharmacol (2006) 0.77
Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability. Ther Drug Monit (2016) 0.77
Antiepileptic drug treatment of children at a referral centre for epilepsy--does admission make a difference? Seizure (2009) 0.76
Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors. Epilepsy Behav (2008) 0.76
Interlaboratory variability in the quantification of new generation antiepileptic drugs based on external quality assessment data. Epilepsia (2003) 0.76
[Epilepsy and driving licenses]. Tidsskr Nor Laegeforen (2011) 0.75
Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia (2008) 0.75
[Epilepsy and pregnancy--drug use, seizure control, and complications]. Tidsskr Nor Laegeforen (2006) 0.75
Monozygous twins discordant for epilepsy. Ann Neurol (2002) 0.75
In response: Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study. Epilepsia (2014) 0.75
Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countries. Drug Saf (2003) 0.75
Chance, serendipity and antiepileptic drugs. Tidsskr Nor Laegeforen (2017) 0.75
[Seizure exacerbation caused by antiepileptic drugs]. Tidsskr Nor Laegeforen (2008) 0.75
[Do urine tests for drugs of abuse cover the substances of interest?]. Tidsskr Nor Laegeforen (2011) 0.75
Carbamazepine-induced cutaneous reactions: a simple assay to identify patients carrying the HLA-A*31:01 allele. Scand J Clin Lab Invest (2014) 0.75
[Oral contraceptives in women with epilepsy]. Tidsskr Nor Laegeforen (2003) 0.75
Combined overdose of atomoxetine and methylphenidate in a cytochrome P450 2D6 poor metabolizer. J Clin Psychopharmacol (2007) 0.75
[Epilepsy and rehabilitation]. Tidsskr Nor Laegeforen (2007) 0.75
Tidsskr Nor Laegeforen (2017) 0.75
Quantitative EEG in patients with alcohol-related seizures. Alcohol Clin Exp Res (2010) 0.75
[New definition of epilepsy]. Tidsskr Nor Laegeforen (2015) 0.75
[Toxicological screening of medicines and drugs of abuse in emergency cases]. Tidsskr Nor Laegeforen (2008) 0.75
[Levetiracetam in the treatment of epilepsy]. Tidsskr Nor Laegeforen (2003) 0.75
Harmonised reference ranges for antiepileptic drugs. Tidsskr Nor Laegeforen (2017) 0.75
[Clarification about pregabalin and the Norwegian Prescription Database]. Tidsskr Nor Laegeforen (2011) 0.75
The EEG response to photic stimulation is not increased in alcohol-related seizures. Clin Neurophysiol (2010) 0.75
[Dravet syndrome as a cause of epilepsy and learning disability]. Tidsskr Nor Laegeforen (2012) 0.75
[Dosing of digitoxin in clinical practice]. Tidsskr Nor Laegeforen (2010) 0.75
[Lennox-Gastaut syndrome--course and treatment]. Tidsskr Nor Laegeforen (2011) 0.75